Lilly to test combinations with Merck, Bristol-Myers' cancer drugs
January 13, 2015 at 09:02 AM EST
Jan 13 (Reuters) - Eli Lilly & Co signed two separate deals with Merck & Co Inc and Bristol-Myers Squibb Co to test combinations of its cancer treatments with two recently approved therapies that belong to a promising new class of drugs.